407 related articles for article (PubMed ID: 27192052)
1. Detectable HIV Viral Load in Kenya: Data from a Population-Based Survey.
Cherutich P; Kim AA; Kellogg TA; Sherr K; Waruru A; De Cock KM; Rutherford GW
PLoS One; 2016; 11(5):e0154318. PubMed ID: 27192052
[TBL] [Abstract][Full Text] [Related]
2. Rates and Predictors of Non-Adherence to Antiretroviral Therapy among HIV-Positive Individuals in Kenya: Results from the Second Kenya AIDS Indicator Survey, 2012.
Mukui IN; Ng'ang'a L; Williamson J; Wamicwe JN; Vakil S; Katana A; Kim AA
PLoS One; 2016; 11(12):e0167465. PubMed ID: 27907114
[TBL] [Abstract][Full Text] [Related]
3. Towards achieving the 90-90-90 HIV targets: results from the south African 2017 national HIV survey.
Marinda E; Simbayi L; Zuma K; Zungu N; Moyo S; Kondlo L; Jooste S; Nadol P; Igumbor E; Dietrich C; Briggs-Hagen M
BMC Public Health; 2020 Sep; 20(1):1375. PubMed ID: 32907565
[TBL] [Abstract][Full Text] [Related]
4. Incidences and factors associated with viral suppression or rebound among HIV patients on combination antiretroviral therapy from three counties in Kenya.
Maina EK; Mureithi H; Adan AA; Muriuki J; Lwembe RM; Bukusi EA
Int J Infect Dis; 2020 Aug; 97():151-158. PubMed ID: 32497804
[TBL] [Abstract][Full Text] [Related]
5. Short Communication: Assessing Estimates of HIV Incidence with a Recent Infection Testing Algorithm That Includes Viral Load Testing and Exposure to Antiretroviral Therapy.
Kim AA; Rehle T
AIDS Res Hum Retroviruses; 2018 Oct; 34(10):863-866. PubMed ID: 29926735
[TBL] [Abstract][Full Text] [Related]
6. Impact of Low-level Viremia on Treatment Outcomes During ART - Is it Time to Revise the Definition of Virological Failure?
Poveda E; Crespo M
AIDS Rev; 2018; 20(1):71-72. PubMed ID: 29628513
[TBL] [Abstract][Full Text] [Related]
7. Association between mental disorders with detectable viral load and poor adherence to antiretroviral therapy among adolescents infected with Human Immunodeficiency Virus on follow-up at Chantal Biya Foundation, Cameroon.
Ndongo FA; Kana R; Nono MT; Noah JYA; Ndzie P; Tejiokem MC; Biheng EH; Ndie J; Nkoa TA; Ketchaji A; Ngako JN; Penda CI; Bissek ACZ; Ndombo POK; Hawa HM; Msellati P; Lallemant M; Faye A
J Epidemiol Popul Health; 2024 Apr; 72(2):202193. PubMed ID: 38523399
[TBL] [Abstract][Full Text] [Related]
8. Use of viral load to improve survey estimates of known HIV-positive status and antiretroviral treatment coverage.
Young PW; Zielinski-Gutierrez E; Wamicwe J; Mukui I; Kim AA; Waruru A; Zeh C; Kretzschmar ME; De Cock KM
AIDS; 2020 Mar; 34(4):631-636. PubMed ID: 31794520
[TBL] [Abstract][Full Text] [Related]
9. High levels of adherence and viral suppression in a nationally representative sample of HIV-infected adults on antiretroviral therapy for 6, 12 and 18 months in Rwanda.
Elul B; Basinga P; Nuwagaba-Biribonwoha H; Saito S; Horowitz D; Nash D; Mugabo J; Mugisha V; Rugigana E; Nkunda R; Asiimwe A
PLoS One; 2013; 8(1):e53586. PubMed ID: 23326462
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with recent unsuppressed viral load in HIV-1-infected patients in care on first-line antiretroviral therapy in South Africa.
Joseph Davey D; Abrahams Z; Feinberg M; Prins M; Serrao C; Medeossi B; Darkoh E
Int J STD AIDS; 2018 May; 29(6):603-610. PubMed ID: 29334886
[TBL] [Abstract][Full Text] [Related]
11. Molecular biological assessment methods and understanding the course of the HIV infection.
Katzenstein TL
APMIS Suppl; 2003; (114):1-37. PubMed ID: 14626050
[TBL] [Abstract][Full Text] [Related]
12. A comparison of self-report and antiretroviral detection to inform estimates of antiretroviral therapy coverage, viral load suppression and HIV incidence in Kwazulu-Natal, South Africa.
Huerga H; Shiferie F; Grebe E; Giuliani R; Farhat JB; Van-Cutsem G; Cohen K
BMC Infect Dis; 2017 Sep; 17(1):653. PubMed ID: 28969607
[TBL] [Abstract][Full Text] [Related]
13. Tuberculosis and HIV at the national level in Kenya: results from the Second Kenya AIDS Indicator Survey.
Mbithi A; Gichangi A; Kim AA; Katana A; Weyenga H; Williamson J; Robinson K; Oluoch T; Maina WK; Kellogg TA; De Cock KM;
J Acquir Immune Defic Syndr; 2014 May; 66 Suppl 1(Suppl 1):S106-15. PubMed ID: 24732814
[TBL] [Abstract][Full Text] [Related]
14. Very high baseline HIV viremia impairs efficacy of non-nucleoside reverse transcriptase inhibitor-based ART: a long-term observation in treatment-naïve patients.
Chen S; Han Y; Song XJ; Li YL; Zhu T; Lu HZ; Tang XP; Zhang T; Zhao M; He Y; He SH; Wang M; Li YZ; Huang SB; Li Y; Liu J; Cao W; Li TS
Infect Dis Poverty; 2020 Jun; 9(1):75. PubMed ID: 32571409
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 drug resistance profiles in children and adults with viral load of <50 copies/ml receiving combination therapy.
Hermankova M; Ray SC; Ruff C; Powell-Davis M; Ingersoll R; D'Aquila RT; Quinn TC; Siliciano JD; Siliciano RF; Persaud D
JAMA; 2001 Jul; 286(2):196-207. PubMed ID: 11448283
[TBL] [Abstract][Full Text] [Related]
16. Impact of low-level viremia on clinical and virological outcomes in treated HIV-1-infected patients.
; Vandenhende MA; Ingle S; May M; Chene G; Zangerle R; Van Sighem A; Gill MJ; Schwarze-Zander C; Hernandez-Novoa B; Obel N; Kirk O; Abgrall S; Guest J; Samji H; D'Arminio Monforte A; Llibre JM; Smith C; Cavassini M; Burkholder GA; Shepherd B; Crane HM; Sterne J; Morlat P
AIDS; 2015 Jan; 29(3):373-83. PubMed ID: 25686685
[TBL] [Abstract][Full Text] [Related]
17. Very low level viraemia and risk of virological failure in treated HIV-1-infected patients.
Teira R; Vidal F; Muñoz-Sánchez P; Geijo P; Viciana P; Ribera E; Domingo P; Castaño M; Martínez E; Roca B; Puig T; Estrada V; Deig E; Galindo MJ; de la Fuente B; Lozano F; Montero M; Muñoz-Sanz A; Sanchez T; Terrón A; Romero-Palacios A; Lacalle JR; Garrido M; Suárez-Lozano I;
HIV Med; 2017 Mar; 18(3):196-203. PubMed ID: 27476742
[TBL] [Abstract][Full Text] [Related]
18. The epidemiology of HIV population viral load in twelve sub-Saharan African countries.
Hladik W; Stupp P; McCracken SD; Justman J; Ndongmo C; Shang J; Dokubo EK; Gummerson E; Koui I; Bodika S; Lobognon R; Brou H; Ryan C; Brown K; Nuwagaba-Biribonwoha H; Kingwara L; Young P; Bronson M; Chege D; Malewo O; Mengistu Y; Koen F; Jahn A; Auld A; Jonnalagadda S; Radin E; Hamunime N; Williams DB; Kayirangwa E; Mugisha V; Mdodo R; Delgado S; Kirungi W; Nelson L; West C; Biraro S; Dzekedzeke K; Barradas D; Mugurungi O; Balachandra S; Kilmarx PH; Musuka G; Patel H; Parekh B; Sleeman K; Domaoal RA; Rutherford G; Motsoane T; Bissek AZ; Farahani M; Voetsch AC
PLoS One; 2023; 18(6):e0275560. PubMed ID: 37363921
[TBL] [Abstract][Full Text] [Related]
19. Multivariate analysis of covariates of adherence among HIV-positive mothers with low viral suppression.
Nsubuga-Nyombi T; Sensalire S; Karamagi E; Aloyo J; Byabagambi J; Rahimzai M; Nabitaka LK; Calnan J
AIDS Res Ther; 2018 Mar; 15(1):9. PubMed ID: 29604955
[TBL] [Abstract][Full Text] [Related]
20. High level of virological suppression among HIV-infected adults receiving combination antiretroviral therapy in Addis Ababa, Ethiopia.
Mekuria LA; Nieuwkerk PT; Yalew AW; Sprangers MA; Prins JM
Antivir Ther; 2016; 21(5):385-96. PubMed ID: 26731316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
